Eclipx Def Set soars 20% on market debut

Does this vehicle fleet management company still look cheap after 20% rise?

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Shares in fleet management and car financing company Eclipx Def Set (ASX: ECX) have climbed more than 20% above their listing price of $2.30 to trade at $2.77, in late afternoon trading.

The company raised $253 million from the sale of 110 million shares, and the jump is no real surprise given the attractive price offered. At $2.30, Eclipx was trading on a 2015 financial year P/E of just 11x and expected to pay a pro-forma, annualised dividend yield of between 4.8% and 5.6%.

Eclipx provides vehicle fleet leasing and management, consumer vehicle finance (including novated leases and chattel mortgages) and commercial equipment finance and leasing. The company says it has around 10% market share in fleet management, and competes against the likes of SG Fleet Group Ltd (ASX: SGF), McMillan Shakespeare Limited (ASX: MMS), Smartgroup Corporation Ltd (ASX: SIQ), LeasePlan, Toyota Financial Services, Custom Fleet (GE), ORIX and Summit.

McMillan trades on a trailing P/E ratio of 13.5x and is paying a 4.7% trailing dividend, while SG Fleet sports a 14.6x P/E ratio for the 2015 financial year, suggesting Eclipx was offered at a discounted price to ensure a successful IPO.

The biggest problem for all three companies, and indeed any companies providing goods and services subject to Fringe Benefits Tax (FBT) such as novated leases on employee cars, is the threat by the Labor Party to change the FBT rules.

You may recall back in 2013 when the government proposed changes to the FBT concessions. At the time, McMillan's shares fell 50% on the news over several days. The companies above all have varying exposure to potential changes to FBT, so Eclipx may well have a very small or close to zero exposure.

It's just one thing to keep in mind when considering an investment in the companies above, including Eclipx. Make sure you do your homework.

Motley Fool contributor Mike King has no position in any stocks mentioned. You can follow Mike on Twitter @TMFKinga The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »